Source: Biology of blood and marrow transplantation. Unidade: FM
Subjects: CÉLULAS-TRONCO, DOENÇA ENXERTO-HOSPEDEIRO, INFÂNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Juliana Folloni et al. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases. Biology of blood and marrow transplantation, v. 26, n. 10, p. 1923-1929, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbmt.2020.07.003. Acesso em: 17 maio 2024.APA
Fernandes, J. F., Nichele, S., Arcuri, L. J., Ribeiro, L., Zamperlini-Netto, G., Loth, G., et al. (2020). Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases. Biology of blood and marrow transplantation, 26( 10), 1923-1929. doi:10.1016/j.bbmt.2020.07.003NLM
Fernandes JF, Nichele S, Arcuri LJ, Ribeiro L, Zamperlini-Netto G, Loth G, Rodrigues ALM, Kuwahara C, Koliski A, Rocha VG. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases [Internet]. Biology of blood and marrow transplantation. 2020 ; 26( 10): 1923-1929.[citado 2024 maio 17 ] Available from: https://doi.org/10.1016/j.bbmt.2020.07.003Vancouver
Fernandes JF, Nichele S, Arcuri LJ, Ribeiro L, Zamperlini-Netto G, Loth G, Rodrigues ALM, Kuwahara C, Koliski A, Rocha VG. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases [Internet]. Biology of blood and marrow transplantation. 2020 ; 26( 10): 1923-1929.[citado 2024 maio 17 ] Available from: https://doi.org/10.1016/j.bbmt.2020.07.003